These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21347839)

  • 21. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
    Liu H; Jia L; Chen X; Shi L; Xie J
    Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson's disease.
    Sarookhani MR; Haghdoost-Yazdi H; Sarbazi-Golezari A; Babayan-Tazehkand A; Rastgoo N
    Behav Pharmacol; 2018 Jun; 29(4):336-343. PubMed ID: 29239973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson's disease.
    Stenslik MJ; Potts LF; Sonne JW; Cass WA; Turchan-Cholewo J; Pomerleau F; Huettl P; Ai Y; Gash DM; Gerhardt GA; Bradley LH
    J Neurosci Methods; 2015 Aug; 251():120-9. PubMed ID: 25999268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rotational behaviour and neurochemical changes in unilateral N-methyl-norsalsolinol and 6-hydroxydopamine lesioned rats.
    Moser A; Siebecker F; Nobbe F; Böhme V
    Exp Brain Res; 1996 Nov; 112(1):89-95. PubMed ID: 8951410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subacute toluene exposure increases DA dysfunction in the 6-OH dopamine lesioned nigrostriatal dopaminergic system of the rat.
    Cintra A; Andbjer B; Finnman UB; Hagman M; Agnati LF; Höglund G; Fuxe K
    Neurosci Lett; 1996 Oct; 217(1):61-5. PubMed ID: 8905740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice.
    Mickley KR; Dluzen DE
    Neuroendocrinology; 2004; 79(6):305-16. PubMed ID: 15256808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine].
    Meng JL; Ma YY; Luo HY; Kong SZ; He YW; Dong BC; Wu SH; He M
    Sheng Li Xue Bao; 2008 Jun; 60(3):369-74. PubMed ID: 18560728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
    Vernon AC; Zbarsky V; Datla KP; Croucher MJ; Dexter DT
    J Neurochem; 2007 Nov; 103(3):1075-91. PubMed ID: 17714448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra.
    Costa G; Abin-Carriquiry JA; Dajas F
    Brain Res; 2001 Jan; 888(2):336-342. PubMed ID: 11150495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition.
    McArthur S; Murray HE; Dhankot A; Dexter DT; Gillies GE
    J Neurochem; 2007 Feb; 100(3):678-92. PubMed ID: 17116232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory process in Parkinson disease: neuroprotection by neuropeptide Y.
    Pain S; Vergote J; Gulhan Z; Bodard S; Chalon S; Gaillard A
    Fundam Clin Pharmacol; 2019 Oct; 33(5):544-548. PubMed ID: 30866091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease.
    Fletcher EJR; Moon LDF; Duty S
    BMC Neurosci; 2019 Dec; 20(1):61. PubMed ID: 31862005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is nicotine protective against Parkinson's disease? An experimental analysis.
    García-Montes JR; Boronat-García A; López-Colomé AM; Bargas J; Guerra-Crespo M; Drucker-Colín R
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):897-906. PubMed ID: 23131151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.
    Fuxe K; Janson AM; Rosén L; Finnman UB; Tanganelli S; Morari M; Goldstein M; Agnati LF
    Exp Brain Res; 1992; 88(1):117-30. PubMed ID: 1347270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system.
    Gao X; Dluzen DE
    Neuroscience; 2001; 103(2):385-94. PubMed ID: 11246153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nigrostriatal damage with 6-OHDA: validation of routinely applied procedures.
    Fulceri F; Biagioni F; Lenzi P; Falleni A; Gesi M; Ruggieri S; Fornai F
    Ann N Y Acad Sci; 2006 Aug; 1074():344-8. PubMed ID: 17105931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
    Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW
    Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine.
    Dluzen D
    Brain Res; 1997 Sep; 767(2):340-4. PubMed ID: 9367266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease.
    Quesada A; Lee BY; Micevych PE
    Dev Neurobiol; 2008 Apr; 68(5):632-44. PubMed ID: 18278798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions.
    Datla KP; Blunt SB; Dexter DT
    Mov Disord; 2001 May; 16(3):424-34. PubMed ID: 11391735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.